Delivery Order SPE2DR25D3012-SPE2DR26F4F1G
- Not listed
- The Defense Logistics Agency awarded a $3,297.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ACTEMRA 400 mg/20 ml vials on June 26, 2025, with an ultimate completion date of June 27, 2025. This non-set-aside contract represents a pharmaceutical supply delivery under the company's larger indefinite delivery contract vehicle with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal...
- The Defense Logistics Agency awarded a $39,176.41 delivery order to AmerisourceBergen Drug Corp for the supply of Actemra 400 mg/20 mL vials on December 9, 2025, with an ultimate completion date of December 10, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $10,525.48 delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Actemra 400 mg/20 mL vials. This competitive award utilizes a firm fixed-price contract structure with a completion date of December 3, 2025, and involves performance at the vendor's facility in Conshohocken, Pennsylvania. The contract contains no set-aside designation, indicating it was competed among qualified vendors in the open market. This delivery order...
- The Defense Logistics Agency awarded a $28,150.37 delivery order to AmerisourceBergen Drug Corp for the supply of Actemra 400 mg/20 ml vials. This competitively awarded, firm fixed-price contract was issued on November 25, 2025, with an ultimate completion date of November 26, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary distribution operations. No set-aside designation was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Actemra 400 mg/20 mL vials with a ceiling value of $6,595.84. This non-set-aside contract award was competitively procured on a firm fixed-price basis, with an ultimate completion date of August 19, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Actemra 80 mg/4 mL vials, with a ceiling value of $1,924.58 and an ultimate completion date of December 16, 2025. This non-set-aside, firm fixed-price delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be performed at...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $13,716.79 on December 18, 2025, for the supply of Actemra 400 mg/20 mL vials. The award is unset-aside and competitively issued under a firm fixed-price delivery order contract, with performance to be completed by December 19, 2025, at the vendor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a $19,352.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ACTEMRA 400 mg/20 mL vials. The contract, executed on August 6, 2025, with ultimate completion by August 7, 2025, represents a competitively awarded non-set-aside procurement with performance to be completed in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency valued at $16,717.53 for the supply of ACTEMRA 162 mg/0.9 mL syringes. The contract is a firm fixed-price delivery order with an ultimate completion date of September 25, 2025, and was competitively awarded without set-aside designation. This award is a child contract issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $39,386.96 to AmerisourceBergen Drug Corp for the supply of Actemra 400 mg/20 mL vials on November 28, 2025, with an ultimate completion date of December 1, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal...
- SPE2DR25D3012Indefinite Delivery Contract
- SPE2DR25D3012-SPE2DR26F4F1GDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,416.20 to AmerisourceBergen Drug Corp for ACTEMRA 400 mg/20 ml vials on January 15, 2026, with an ultimate completion date of January 16, 2026. This firm fixed-price, non-set-aside delivery order is being performed at the contractor's Conshohocken, Pennsylvania location. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, which is valued at up to $999,999,999.00 through December 2031 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. Cencora, Inc., operating as AmerisourceBergen, is a major pharmaceutical distributor and healthcare solutions provider that supplies a broad portfolio of medications and medical commodities to federal agencies. This specific delivery order for ACTEMRA, a prescription pharmaceutical product, exemplifies the company's role in fulfilling critical medical supply requirements for the Defense Health Agency and other military healthcare systems. The contract was competitively awarded through open competition with no small business set-asides, reflecting the contractor's demonstrated capability to meet federal procurement standards for pharmaceutical products across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 1/14/26 |